Significance of CD30-positive lymphocytes in livers in primary biliary cirrhosis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 14, Issue 12, 1999, Pages 1197-1202

  Harada, Ken Ichi ^a   Tsuneyama, Koichi ^a   Hiramatsu, Katsushi ^a   Nakanuma, Yasuni ^a  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Antimitochondrial antibody; CD30; Primary biliary cirrhosis

Indexed keywords

CD30 ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MITOCHONDRION ANTIBODY;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CELLULAR IMMUNITY; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; EXTRAHEPATIC BILE DUCT OBSTRUCTION; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INTRAHEPATIC BILE DUCT; MALE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0033427620     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.1999.02029.x     Document Type: Article

References (31)

1. 1 Rubin E, Schaffner F, Popper H. Primary biliary cirrhosis. Am. J. Pathol. 1965; 46: 387-407.
2. 2 Kaplan MM, Gandolfo JV, Quaroni EG. An enzyme-linked immunosorbent assay (ELISA) for detecting antimitochondrial antibody. Hepatology 1984; 4: 727-30.
3. 3 Gershwin ME, Mackay IR, Sturgess A, Coppel RL. Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis. J. Immunol. 1987; 138: 3525-31.
4. 4 Van de Water J, Ansari AA, Surh CD et al. Evidence for the targeting by 2-oxo-dehydrogenase enzymes in the T cell response of primary biliary cirrhosis. J. Immunol. 1991; 146: 89-94.
5. 5 Harada K, Van de Water J, Leung PS et al. In situ nucleic acid hybridization of cytokines in primary biliary cirrhosis: Predominance of the Th1 subset. Hepatology 1997; 25: 791-6.
6. 6 Van de Water J, Shimoda S, Niho Y, Coppel R, Ansari A, Gershwin ME. The role of T cells in primary biliary cirrhosis. Semin. Liver Dis. 1997; 17: 105-13.
7. 7 Nishio A, Van de Water J, Leung PS et al. Comparative studies of antimitochondrial autoantibodies in sera and bile in primary biliary cirrhosis. Hepatology 1997; 25: 1085-9.
8. 8 Nakanuma Y. Distribution of B lymphocytes in nonsuppurative cholangitis in primary biliary cirrhosis. Hepatology 1993; 18: 570-5.
9. 9 Bjorkland A, Loof L, Mendel Hartvig I, Totterman TH. Primary biliary cirrhosis. High proportions of B cells in blood and liver tissue produce anti-mitochondrial antibodies of several Ig classes. J. Immunol. 1994; 153: 2750-7.
10. 10 Schwab U, Stein H, Gerdes J et al. Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature 1982; 299: 65-7.
11. 11 Alzona M, Jack HM, Fisher RI, Ellis TM. CD30 defines a subset of activated human T cells that produce IFN-gamma and IL-5 and exhibit enhanced B cell helper activity. J. Immunol. 1994; 153: 2861-7.
12. 12 Romagnani S. Th1 and Th2 in human diseases. Clin. Immunol. Immunopathol. 1996; 80: 225-35.
13. 13 Del Prete G, De Carli M, Almerigogna F et al. Preferential expression of CD30 by human CD4+T cells producing Th2-type cytokines. Faseb J. 1995; 9: 81-6.
14. 14 Schwarting R, Gerdes J, Durkop H, Falini B, Pileri S, Stein H. BER-H2: A new anti-Ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitope. Blood 1989; 74: 1678-89.
15. 15 Moller P, Matthaei Maurer DU, Moldenhauer G. CD30 (Ki-1) antigen expression in a subset of gastric mucosal plasma cells and in a primary gastric plasmacytoma. Am. J. Clin. Pathol. 1989; 91: 18-23.
16. 16 Shanebeck KD, Maliszewski CR, Kennedy MK et al. Regulation of murine B cell growth and differentiation by CD30 ligand. Eur. J. Immunol. 1995; 25: 2147-53.
17. 17 Gruss HJ, Boiani N, Williams DE, Armitage RJ, Smith CA, Goodwin RG. Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines. Blood 1994; 83: 2045-56.
18. 18 Bowen MA, Lee RK, Miragliotta G, Nam SY, Podack ER. Structure and expression of murine CD30 and its role in cytokine production. J. Immunol. 1996; 156: 442-9.
19. 19 Gruss HJ, Ulrich D, Dower SK, Herrmann F, Brach MA. Activation of Hodgkin cells via the CD30 receptor induces autocrine secretion of interleukin-6 engaging the NF-kappabeta transcription factor. Blood 1996; 87: 2443-9.
20. 20 Okumura M, Hidaka Y, Kuroda S, Takeoka K, Tada H, Amino N. Increased serum concentration of soluble CD30 in patients with Graves' disease and Hashimoto's thyroiditis. J. Clin. Endocrinol. Metab. 1997; 82: 1757-60.
21. 21 Krams SM, Cao S, Hayashi M, Villanueva JC, Martinez OM. Elevations in IFN-gamma, IL-5, and IL-10 in patients with the autoimmune disease primary biliary cirrhosis: Association with autoantibodies and soluble CD30. Clin. Immunol. Immunopathol. 1996; 80: 311-20.
22. 22 Mavalia C, Scaletti C, Romagnani P et al. Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis. Am. J. Pathol. 1751; 1997: 151-8.
23. 23 Ludwig J, Dickson ER, McDonald GS. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch. A Pathol. Anat. Histol. 1978; 379: 103-12.
24. 24 Walker JG, Doniach D, Roitt IM, Sherlock S, Serological tests in the diagnosis of primary biliary cirrhosis. Lancet 1965; 1: 827-30.
25. 25 Mosmann T, Cherwinski H, Bond M, Giedlin M, Coffman R.L. Two types of murine helper T cell clone I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 1986; 136: 2348-57.
26. 26 Paul W, Seder R. Lymphocyte responses and cytokines. Cell 1994; 76: 241-51.
27. 27 Hamann D, Hilkens CM, Grogan JL et al. CD30 expression does not discriminate between human Th1-and Th2-type T cells. J. Immunol. 1996; 156: 1387-91.
28. 28 Krams SM, Van de Water J, Coppel RL et al. Analysis of hepatic T lymphocyte and immunoglobulin deposits in patients with primary biliary cirrhosis. Hepatology 1990; 12: 306-13.
29. 29 Chesnut RW, Grey HM. Antigen presentation by B cells and its significance in T-B interactions. Adv. Immunol. 1986; 39: 51-94.
30. 30 Ashwell JD. Are B lymphocytes the principal antigen-presenting cells in vivo? J. Immunol. 1988; 140: 3697-700.
31. 31 Nagura H,Tsutsumi Y, Hasegawa H, Watanabe K, Nakane P, Brown W. IgA plasma cells in biliary mucosa: A likely source of locally synthesized IgA in human hepatic bile. Clin. Exp. Immunol. 1983; 54: 671-80.